(NASDAQ: TECH) Bio Techne's forecast annual revenue growth rate of 4.69% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 218.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.67%.
Bio Techne's revenue in 2025 is $1,219,635,000.On average, 6 Wall Street analysts forecast TECH's revenue for 2026 to be $194,791,947,908, with the lowest TECH revenue forecast at $191,777,085,812, and the highest TECH revenue forecast at $204,547,706,905.
In 2027, TECH is forecast to generate $207,933,710,315 in revenue, with the lowest revenue forecast at $205,045,465,583 and the highest revenue forecast at $211,425,331,894.